Clinical trials in Bratislava – page 7

277 clinical trials in Bratislava, Slovakia across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SlovakiaKlinickeSkusky.sk

Bratislava at a glance

277

clinical trials

Research sites6

Quick filters

277 trials in Bratislava

Open in trial search

Neurogenic bladder

Recruiting

Study on the Safety and Effectiveness of Vibegron for Children Aged 2 to 17 with Neurogenic Bladder Overactivity Using Clean Intermittent Catheterization

InvestigationalNo placebo

Study on the Safety and Effectiveness of Vibegron for Children Aged 2 to 17 with Neurogenic Bladder Overactivity Using Clean Intermittent Catheterization

InvestigationalNo placebo

Slovakia

Participants:0–17 years
Substances:Vibegron
Sponsor:Sumitomo Pharma America Inc.

Contact Research Centre

Acute lymphocytic leukaemia

Recruiting

Study Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia

Registered drugNo placebo

Study Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia

Registered drugNo placebo

Slovakia

Participants:0–17 years
Substances:Crisantaspase
Sponsor:Pfizer Inc.

Contact Research Centre

Anaemia of chronic disease

Recruiting

Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

Registered drugNo placebo

Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Darbepoetin Alfa
Sponsor:Genexine Inc.

Contact Research Centre

Acute myeloid leukaemia+3

Recruiting

Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

InvestigationalNo placebo

Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

InvestigationalNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Cedazuridine
Sponsor:Taiho Oncology Inc.

Contact Research Centre

Neuroblastoma

Recruiting

Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

Registered drugNo placebo

Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

Registered drugNo placebo

Slovakia

Participants:0–17 years · 18–64 years
Substances:Busulfan
Sponsor:Institut Gustave Roussy

Contact Research Centre

Pulmonary arterial hypertension

Recruiting

Study on the Safety and Tolerability of Treprostinil Sodium for Children with Pulmonary Arterial Hypertension

InvestigationalNo placebo

Study on the Safety and Tolerability of Treprostinil Sodium for Children with Pulmonary Arterial Hypertension

InvestigationalNo placebo

Slovakia

Participants:0–17 years
Substances:Treprostinil Sodium
Sponsor:Aop Orphan Pharmaceuticals GmbH

Contact Research Centre

Anaplastic large cell lymphoma T- and null-cell types+3

Recruiting

Study of Crizotinib and Temsirolimus for Children with ALK, ROS1, or MET Positive Cancers, Including Neuroblastoma and Rhabdomyosarcoma

Registered drugNo placebo

Study of Crizotinib and Temsirolimus for Children with ALK, ROS1, or MET Positive Cancers, Including Neuroblastoma and Rhabdomyosarcoma

Registered drugNo placebo

Slovakia

Participants:0–17 years · 18–64 years
Substances:Crizotinib
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Hormone-refractory prostate cancer

Recruiting

Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

Registered drugNo placebo

Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Non-small cell lung cancer

Recruiting

Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

Registered drug

Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:MRNA-4157
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Study on N-Acetyl-L-Leucine for Patients with Niemann-Pick Disease Type C

Recruiting

Investigational

Study on N-Acetyl-L-Leucine for Patients with Niemann-Pick Disease Type C

Investigational

Slovakia

Participants:0–17 years · 18–64 years
Substances:L-Acetylleucine
Sponsor:Intrabio Limited

Contact Research Centre

Non-Hodgkin's lymphoma

Recruiting

Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

Registered drugNo placebo

Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

Registered drugNo placebo

Slovakia

Participants:0–17 years
Substances:Cyclophosphamide
Sponsor:Universitaetsklinikum Muenster AöR

Contact Research Centre

Haematological malignancy+1

Recruiting

Study on the Safety and Effectiveness of Zilovertamab Vedotin for Children and Young Adults with Blood Cancers or Solid Tumors

InvestigationalNo placebo

Study on the Safety and Effectiveness of Zilovertamab Vedotin for Children and Young Adults with Blood Cancers or Solid Tumors

InvestigationalNo placebo

Slovakia

Participants:0–17 years · 18–64 years
Substances:Zilovertamab Vedotin
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Bratislava

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on non-small cell lung cancer and advanced breast cancer treatments. Studies include evaluation of novel therapies like sigvotatug vedotin and investigations into treatment combinations for metastatic prostate cancer.

Lung Cancer Therapeutics
Breast Cancer Treatment
Prostate Cancer Research

Research includes evaluations of combination therapies and targeted treatments for various stages of cancer.

02 Cardiovascular Studies

Comprehensive research into heart failure prevention and treatment of cardiovascular diseases. Studies examine innovative approaches using medications like baxdrostat and investigating treatments for patients following heart attacks.

Heart Failure Prevention
Post-Heart Attack Care
Cardiovascular Risk Management

Focus on developing preventive strategies and improving patient outcomes in cardiovascular conditions.

03 Inflammatory Conditions

Studies addressing various inflammatory conditions including Crohn's disease and ulcerative colitis. Research evaluates new therapeutic approaches for chronic inflammatory disorders and autoimmune conditions.

Inflammatory Bowel Disease
Hidradenitis Suppurativa
Chronic Inflammatory Disorders

Trials aim to improve treatment options and quality of life for patients with chronic inflammatory conditions.

Back to Slovakia All countries